| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2567.2005.02270.X |
| P698 | PubMed publication ID | 16423045 |
| P2093 | author name string | Mutsuhiko Minami | |
| Chie Hotta | |||
| Masahiro Yoshinari | |||
| Haruka Fujimaki | |||
| Masatoshi Nakazawa | |||
| P2860 | cites work | A receptor for the selective uptake and degradation of proteins by lysosomes | Q24319797 |
| Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products | Q24678867 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes | Q28609747 | ||
| An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow | Q29615498 | ||
| Degradation of cell proteins and the generation of MHC class I-presented peptides | Q33652524 | ||
| Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines | Q33683185 | ||
| Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. | Q33699321 | ||
| Cross-presentation of tumour antigens: evaluation of threshold, duration, distribution and regulation. | Q33778847 | ||
| Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen | Q33855119 | ||
| Lysosome-endosome fusion and lysosome biogenesis. | Q33883540 | ||
| Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay | Q33903838 | ||
| Cross-presentation, dendritic cells, tolerance and immunity | Q34178099 | ||
| The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing | Q34310837 | ||
| Ammonium chloride, an inhibitor of phagosome-lysosome fusion in macrophages, concurrently induces phagosome-endosome fusion, and opens a novel pathway: studies of a pathogenic mycobacterium and a nonpathogenic yeast | Q36230420 | ||
| Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells. | Q36301521 | ||
| Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization | Q36367948 | ||
| The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli | Q36368355 | ||
| Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation | Q36376648 | ||
| Acidification of the endocytic and exocytic pathways | Q39459758 | ||
| Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells. | Q40481734 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| Acidification of lysosomes and endosomes. | Q40955124 | ||
| Intracellular routes and selective retention of antigens in mildly acidic cathepsin D/lysosome-associated membrane protein-1/MHC class II-positive vesicles in immature dendritic cells | Q41086442 | ||
| A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules | Q41380874 | ||
| Dendritic cell development and maturation. | Q41586693 | ||
| Role of acidic intracellular compartments in the biosynthesis of Dictyostelium lysosomal enzymes. The weak bases ammonium chloride and chloroquine differentially affect proteolytic processing and sorting | Q41946234 | ||
| Activation of lysosomal function during dendritic cell maturation | Q44333919 | ||
| Developmental control of endocytosis in dendritic cells by Cdc42. | Q50119612 | ||
| Phagocytic processing of bacterial antigens for class I MHC presentation to T cells | Q50167043 | ||
| Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. | Q50335818 | ||
| Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. | Q50335820 | ||
| Phagosomes are fully competent antigen-processing organelles that mediate the formation of peptide:class II MHC complexes. | Q50335824 | ||
| Rac is required for constitutive macropinocytosis by dendritic cells but does not control its downregulation. | Q52166799 | ||
| Enhanced Dendritic Cell Antigen Capture via Toll-Like Receptor-Induced Actin Remodeling | Q57204114 | ||
| CD36 Is Differentially Expressed by CD8+ Splenic Dendritic Cells But Is Not Required for Cross-Presentation In Vivo | Q57227860 | ||
| Cross-presentation: a general mechanism for CTL immunity and tolerance | Q57228022 | ||
| Regulation of phagolysosome pH in bovine and human neutrophils: the role of NADPH oxidase activity and an Na+/H+ antiporter | Q69334990 | ||
| TAP1-independent loading of class I molecules by exogenous viral proteins | Q71889597 | ||
| Transport of peptide-MHC class II complexes in developing dendritic cells | Q73698434 | ||
| P433 | issue | 1 | |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 97-107 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Immunology | Q15754984 |
| P1476 | title | The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells | |
| P478 | volume | 117 |
| Q58799522 | A novel probe to assess cytosolic entry of exogenous proteins |
| Q42088817 | A role for lipid bodies in the cross-presentation of phagocytosed antigens by MHC class I in dendritic cells |
| Q89654435 | C-Mannosyl Lysine for Solid Phase Assembly of Mannosylated Peptide Conjugate Cancer Vaccines |
| Q46304257 | Cross, but not direct, presentation of cell-associated virus antigens by spleen macrophages is influenced by their differentiation state |
| Q26799991 | Cross-Presentation of Cell-Associated Antigens by MHC Class I in Dendritic Cell Subsets |
| Q35108299 | Cross-presentation of synthetic long peptides by human dendritic cells: a process dependent on ERAD component p97/VCP but Not sec61 and/or Derlin-1. |
| Q38008346 | Cross-presentation: how to get there - or how to get the ER. |
| Q37114832 | Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses |
| Q34661797 | Dendritic cell-based vaccines: barriers and opportunities |
| Q41926871 | Enhancement of T cell-mediated immune responses to whole inactivated influenza virus by chloroquine treatment in vivo |
| Q35221169 | H9N2 influenza whole inactivated virus combined with polyethyleneimine strongly enhances mucosal and systemic immunity after intranasal immunization in mice |
| Q34513978 | Improved antigen cross-presentation by polyethyleneimine-based nanoparticles |
| Q33614657 | Linear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunity |
| Q33906222 | Modifying Dendritic Cell Activation with Plasmonic Nano Vectors |
| Q38020769 | Particulate systems for targeting of macrophages: basic and therapeutic concepts. |
| Q36933020 | Primary CD8+ T-cell response to soluble ovalbumin is improved by chloroquine treatment in vivo |
| Q61807977 | Regulation of Antigen Export to the Cytosol During Cross-Presentation |
| Q55056670 | Self-homodimerization of an actinoporin by disulfide bridging reveals implications for their structure and pore formation. |
| Q46674193 | Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation |
| Q40567547 | The lectin Siglec-G inhibits dendritic cell cross-presentation by impairing MHC class I-peptide complex formation |
| Q38772920 | The ongoing saga of the mechanism(s) of MHC class I-restricted cross-presentation |
| Q35774599 | Vaccinia virus infection of mature dendritic cells results in activation of virus-specific naïve CD8+ T cells: a potential mechanism for direct presentation |
| Q64059399 | Vector uncoating limits adeno-associated viral vector-mediated transduction of human dendritic cells and vector immunogenicity |
Search more.